
Sign up to save your podcasts
Or


AstraZeneca vaccine shows 79% efficacy in trials but is not without controversy; Everlywell acquires PWNHealth and subsidiary Home Access Health . Plus: U.S. Department of Veterans Affairs undertaking a strategic review of its Cerner electronic health record modernization program .
Links to the stories:
AstraZeneca vaccine shows 79% efficacy in phase III trial
AstraZeneca is questioned over potential use of outdated information in its COVID-19 clinical trial
Everlywell forms new at-home lab testing subsidiary through PWNHealth purchase
VA to undertake strategic review of EHR modernization program
By HIMSS Media4.6
1111 ratings
AstraZeneca vaccine shows 79% efficacy in trials but is not without controversy; Everlywell acquires PWNHealth and subsidiary Home Access Health . Plus: U.S. Department of Veterans Affairs undertaking a strategic review of its Cerner electronic health record modernization program .
Links to the stories:
AstraZeneca vaccine shows 79% efficacy in phase III trial
AstraZeneca is questioned over potential use of outdated information in its COVID-19 clinical trial
Everlywell forms new at-home lab testing subsidiary through PWNHealth purchase
VA to undertake strategic review of EHR modernization program

8,885 Listeners

78,686 Listeners

30,749 Listeners

43,608 Listeners

10,964 Listeners

26,279 Listeners

9,643 Listeners

112,192 Listeners

4,800 Listeners

5,493 Listeners

1,343 Listeners

5,542 Listeners

16,195 Listeners

352 Listeners

1,490 Listeners